SMJ articles in the category "erythropoietin"

Expired CME Article

Clinical Considerations and Practical Recommendations for the Primary Care Practitioner in the Management of Anemia of Chronic Kidney Disease

Anemia is prevalent in patients with chronic kidney disease (CKD) and is a risk factor for poor disease outcome. Anemia acts as a risk multiplier, significantly increasing the risk of death in anemic versus nonanemic CKD patients with similar comorbidities. Erythropoiesis-stimulating agents (ESA) are a mainstay for the treatment of…

Posted in: Cardiovascular Disease 27 chronic kidney disease 13 end-stage renal disease 5 erythropoietin 2 hemoglobin 3

Original Article

Comparison of a Restricted Transfusion Schedule with Erythropoietin Therapy versus a Restricted Transfusion Schedule Alone in Very Low Birth Weight Premature Infants

Objective: Erythropoietin (EPO) is commonly used in very low birth weight neonates to minimize blood transfusions during hospitalization. Data are limited comparing the use of EPO along with a restricted transfusion schedule versus a restricted transfusion schedule alone. We compared the effects of a restricted transfusion schedule with EPO versus…

Posted in: anemia 11 blood transfusion 2 erythropoietin 2 prematurity 3
SMA Menu